Preliminary Scientific Program

“This intensive three-day symposium brings together the world's leading medical scientists to share, in a highly interactive environment, the most recent advances in the field of atrial fibrillation.”


PRELIMINARY PROGRAM SUBJECT TO CHANGE

2017_AF_SYM__318-for-web.jpg

Thursday, January 24

MEDICAL DEVICE AND TECHNOLOGY SYMPOSIUM

Emerging New Technologies: Implications for the Future of Medicine and Cardiology

Artificial Intelligence, Machine Learning & Big Data: Convergence and Automated Innovation

The Future of Robotics in Medicine: Research and Clinical Application

Applications of Virtual and Augmented Reality in Medical Practice and Training

CRISPR/Cas9 Technology: From Disease Modelling to Therapeutic Interventions

What VCs Want and How to Finance a Medical Device Startup

Panel and Audience Discussion**

SPOTLIGHT SESSION: Early Stage and Emerging Technologies in Cardiac Mapping and Ablation

Preliminary Participants:
Acesion Pharma, Acutus, Affera, CardioNXT, EP Dynamics, InCarda, Kardium, LuxCath


10-10:30 AM: Break and Exhibits


NOVEL MAPPING AND ABLATION TECHNOLOGIES FOR CATHETER ABLATION OF ATRIAL FIBRILLATION
Sponsored Session (Non-CME) - Abbott Medical

A Novel Multielectrode/Omnipolar Mapping Technology to Address the Limitations of Traditional Bipolar Mapping

New Insights into Arrhythmia Mechanisms Using a High Density Multielectrode Mapping Array

New Generation Ablation Catheters: Combining Force Sensing with Accurate Catheter Localization

High Power Short Duration Ablation for AF: Unmet Needs and Potential Solutions

Panel and Audience Q&A and Discussion


Noon-1:15 PM: Lunch, Exhibits and Product Theaters


CABANA: NEW ANALYSES, LONG-TERM FOLLOW-UP AND DEBATE—INTERPRETATION AND IMPLICATIONS FOR CLINICAL PRACTICE

Debate and Discussion:

CABANA is a Negative Trial
CABANA is a Positive Trial

Why CABANA Is a Neutral Trial that Isn’t Neutral; New Analyses; Long-Term Follow-up Quality of Life; and Sinus Rhythm vs. Atrial Fibrillation

Essential Lessons Learned from AF Ablation Mortality Trials (ATAAC-AF, CASTLE AF, CABANA)

Panel and Audience Discussion


2:50-3:20 PM: Break and Exhibits


CHALLENGING CASES IN AF MANAGEMENT: DRUGS, ANTICOAGULATION, ABLATION & LAA CLOSURE

Case Presentations and Audience and Panel Discussion


7 - 10 PM
JFK PRESIDENTIAL LIBRARY & MUSEUM DINNER CELEBRATION

All Attendees, Industry and Faculty - Dinner, Networking and Optional Guided Tours

home_page__300.jpg

Friday, January 25

REAL-TIME CASE TRANSMISSIONS: NEW IMAGING, MAPPING AND ABLATION TECHNOLOGIES
Interactive Panel and Audience Discussions

Pulmonary Vein Isolation with Ultrasound Mapping and Ablation
Na Homolce Hospital, Prague, Czech Republic

Convergent Hybrid Ablation for Atrial Fibrillation
Emory Heart and Vascular Center, Saint Joseph’s Hospital, Atlanta, GA
Sponsored Case (Non-CME)- Atricure Inc.

Temperature Controlled High Power Short Duration Focal RF Ablation for AF
Mount Sinai Medical Center, New York, NY

Pulmonary Vein Isolation with a Multi-Electrode Radiofrequency Balloon Catheter
Massachusetts General Hospital, Boston, MA

Pulmonary Vein Isolation with 3-D Cryoballoon Visualization
St. Luke's Medical Center, Aurora Health Care, Milwaukee, WI

Audience & Panel Q&A and Discussion During Cases


10-10:30 AM: Break and Exhibits


NEW TRENDS IN CATHETER ABLATION FOR ATRIAL FIBRILLATION: IMPROVING EFFICACY AND EFFICIENCY
Sponsored Session (Non-CME) - Biosense Webster

Improving Procedural Efficiency: Contributions of Ultrasound and Low Fluoroscopy Procedures

A Tailored Approach to AF Ablation: How to Customize Your Ablation Strategy to the Individual Patient

Shortening Procedure Times and Improving Periprocedural Efficiency: How to Treat More Patients Per Day While Enhancing Quality and Patient Experience

Panel and Audience Discussion


Noon-1:15 PM: Lunch, Exhibits and Product Theaters


NEW TECHNOLOGIES FOR MAPPING AND ABLATION OF ATRIAL FIBRILLATION

Benefits of Ultra High-Density Mapping in AF and AT

Advances in Catheter Technologies for Focal RF Ablation (CFS; Temp Control; Trial Updates)

Catheter Ablation for AF Aiming for Contiguous Lesions and Using a Novel Ablation Tag Index

New Directions in Cryoablation for AF

Update on Balloon Technologies for AF Ablation

Pulsed Electrical Field Ablation for PVI: Preclinical and Clinical Experience

FDA Perspective: How to Balance Patient Safety, Regulatory Requirements and the Need for Innovation to Advance Patient Care in AF Ablation

Panel and Audience Discussion—All Faculty


3:30-4 PM: Break and Exhibits


STROKE PREVENTION IN AF: CURRENT ISSUES IN ANTICOAGULATION, ABLATION AND LAA CLOSURE

Anticoagulation

Update on Completed Trials in Anticoagulation—Clinical Implications

Relationship Between AF Burden and Stroke Risk: What is the Threshold for Anticoagulation?

Pill-in-the-Pocket Anticoagulation in Selected Patients with AF: Rationale, Observational Data and Upcoming Clinical Trials

Should We Discontinue Oral Anticoagulation After Successful Ablation of AF?

Adherence to Anticoagulation in Clinical Practice—Current Data

Panel and Audience Discussion—All Faculty

Left Atrial Appendage Closure

Update on New Technologies and Clinical Trial Outcomes for LAA Closure

LAA Closure in Patients at High Risk for Bleeding

LAA Closure Combined with AF Ablation - Indications, Timing and Outcomes

Management of Complications with LAA Closure

FDA Perspective on New Technologies for Left Atrial Appendage Closure: Challenges and Opportunities

Panel and Audience Discussion—All Faculty

2017_AF_SYM__42-for-web.jpg

Saturday, January 26

BEYOND PVI: MECHANISMS AND TARGETS FOR AF ABLATION

Rotors and Fibrillation Revisited: New Imaging Technologies to Visualize Cardiac Electromechanical Turbulence

Predicting the Outcome of AF Ablation with Personalized Analysis of the Atrial Fibrotic Substrate: Can We Predict if PVI Will Be Sufficient?

Activation Wavefront Rotation: Which Rotors Are “Real” and Which Truly Contribute to Perpetuation of AF?

Comparison of High Resolution Experimental Optical Mapping and Catheter Mapping of AF Patients

New Strategy for Rotor Guided Catheter Ablation of Persistent AF

Strategies for Ablation of Non-PV Triggers in Patients with Resistant AF

A New Single-Procedure Ablation Method for Persistent AF Designed to Minimize Local and Macro-Reentrant Atrial Tachycardias

Panel and Audience Discussion (30 Minutes)—All Faculty


10-11 AM: Continental Breakfast and Exhibits


BEYOND PVI: MECHANISMS AND TARGETS FOR AF ABLATION (Continued)

Role of Vein of Marshall Ablation in Persistent AF

How Will Genetic Screening Influence Strategies for AF Management


HOW TO IMPROVE THE SAFETY OF AF ABLATION PROCEDURES

Feasibility of Continuing Ablation for AF after Pericardiocentesis for Cardiac Tamponade

Relevance and Timing of CT Scans to Diagnose AE Fistula

Strategies for the Prevention of Esophageal Thermal Injury During AF Ablation

Correlation of Post-Ablation MRI Esophageal Findings and Endoscopic Evaluation

Panel and Audience Discussion—All Faculty


LATE-BREAKING CLINICAL TRIALS AND FIRST REPORT CLINICAL INVESTIGATIONS


BEST ABSTRACT AWARD


1:45 PM: Adjourn


TO FOLLOW:
HRS OPENING SESSION FOR GENERAL CARDIOLOGISTS & INTERNISTS


REGISTRATION & BADGE PICK-UP

Wednesday, January 23
Noon - 6:30 PM

Thursday, January 24 and Friday, January 25
6:30 AM - Close


EXPO HALL OPENS

Thursday, January 24
9 AM – 4:30 PM